RSV Vaccinations Remain Low Among Older Americans

The New York Times (12/9, Span) reported, “So far, only about 15 percent of Americans over 60 have received one of the two new R.S.V. shots,” which the FDA approved in May. Public health officials attribute the low uptake to a general lack of knowledge about the vaccine, as well as low awareness of the virus itself. However, the FDA “estimates that the virus sends 60,000 to 160,000 people over 65 to hospitals each year and causes 6,000 to 10,000 deaths.”